Recombinant herpes simplex virus and use thereof Grant US-11680248-B2 United States of America 20 Jun 2023
Enhanced systems for cell-mediated oncolytic viral therapy Grant US-11655455-B2 United States of America 23 May 2023
Cell-based vehicles for potentiation of viral therapy Grant US-11505782-B2 United States of America 22 Nov 2022
Construction of oncolytic herpes simplex viruses (oHSV) obligate vector and constructs… Grant US-11439679-B2 United States of America 13 Sep 2022
Engineered immunostimulatory bacterial strains and uses thereof Grant US-11242528-B2 United States of America 08 Feb 2022
RECOMBINANT HERPES SIMPLEX VIRUS AND USE THEREOF Application EP-3594328-A4 European Patent Office 31 Mar 2021
Construction of oncolytic herpes simplex viruses (oHSV) obligate vector and constructs… Grant US-10821140-B2 United States of America 03 Nov 2020
ENHANCED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY Application WO-2020097269-A1 World Intellectual Property Organisation (WIPO) 14 May 2020
Use of an oncolytic virus for the treatment of cancer Grant US-10626377-B2 United States of America 21 Apr 2020
CELL-BASED VEHICLES FOR POTENTIATION OF VIRAL THERAPY Application WO-2019236633-A2 World Intellectual Property Organisation (WIPO) 12 Dec 2019
CONSTRUCTION OF ONCOLYTIC HERPES SIMPLEX VIRUSES (oHSV) OBLIGATE VECTOR AND CONSTRUCTS… Application EP-3380621-A4 European Patent Office 08 May 2019
ALTERED VIRUS Application WO-2018127713-A1 World Intellectual Property Organisation (WIPO) 12 Jul 2018
USE OF AN ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER Application WO-2017118867-A1 World Intellectual Property Organisation (WIPO) 13 Jul 2017
ONCOLYTIC VIRUS STRAIN Application WO-2017118865-A1 World Intellectual Property Organisation (WIPO) 13 Jul 2017
ENGINEERED VIRUS Application WO-2017118866-A1 World Intellectual Property Organisation (WIPO) 13 Jul 2017
MODIFIED ONCOLYTIC VIURS Application WO-2017118864-A1 World Intellectual Property Organisation (WIPO) 13 Jul 2017